Emerging Industry Professionals and BusinessExpos.com Support Endeavors to Downgrade Cannabis from a Schedule 1 Drug

As reported by NPR in their article “Marijuana could soon be downgraded from a Schedule 1 drug,” the Drug Enforcement Agency (DEA) has begun a review to assess cannabis and if it should still be classified as a Schedule 1 drug.

In a move that is long overdue to many, this review could be game-changing for how cannabis is viewed by the federal government and would be an acknowledgement that the plant has medicinal uses.

“Right now it’s a Schedule 1 drug, the highest level of control, along with LSD, heroin and ecstasy. That means it has a high potential for abuse and no medical uses. On Tuesday, a top health official sent a letter to the Drug Enforcement Administration reportedly recommending that marijuana be downgraded to a Schedule 3 substance, along with ketamine and testosterone,” NPR’s Selena Simmons-Duffin said.

Click here to learn more about the CannaTech industry or click here to read the full article.

Article with all rights reserved, provided by NPR —— https://www.npr.org/

Photo with all rights reserved, provided by Canva —— https://www.canva.com/